Skip to content

An investigation of metallic stent insertion for anastomotic strictures related to Crohn's disease

A pilot study investigating safety and efficacy of metallic stent insertion for ileo-colonic anastomotic strictures related to Crohn's disease.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs022240024
Enrollment
5
Registered
2024-09-18
Start date
2024-09-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ileo-colonic anastomotic stricture related to Crohn's diseaae lower gastointestinal tract stenosis, Crohn's diasese, metallic stent

Interventions

Insertion of metallic stent for ileo-colonic anastomotic stenosis following surgery related to Crohn's disease. Endoscopic removal of stent at one week following stent insertion.

Sponsors

Moroi Rintaro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Adults aged 18 to 80 who have given written consent for participation in the study. (2) Patients with benign strictures (stenosis length is 5cm or less) at the ileocolonic anastomosis after intestinal surgery for Crohn's disease, who have a history of previous endoscopic dilation procedures (balloon dilation, RIC, etc.) (not including history of procedures for stenoses other than anastomotic stenoses). (3) Patients with subjective symptoms such as abdominal distention, abdominal pain, difficulty in defecation, nausea, or any other symptoms presumed to be caused by intestinal stenosis (4) Patients who are capable of outpatient visits (PS: 0-2). (5) Patients who have provided written consent to participate in this clinical study of their own free will.

Exclusion criteria

Exclusion criteria: (1)Patients whose stenosis length exceeds the effective length of the stent (stenosis length is evaluated by fluoroscopic endoscopy with contrast enhanced by gastrografin) (2)With surgical lesion such as stenosis or abscess near the stenosis (surgery is prioritozed) (3)Thin wall at the stenosis site evaluated by ultra sound, computed tomography or magnetic resonance imaging (4)No drug withdrawal possible of anti-platelet drug and anti-coagulant drug (5)Woman with pregnancy, possibility of pregnancy. (6)With psychiatric disorder (7)With severe cardiopulmonary disorder (8)The patients who the doctor judged as inappropriate.

Design outcomes

Primary

MeasureTime frame
The ratio of adverse event of special interest ( delayed bleeding, perforation) from stent insertion to one week after endoscopic removal of metallic stent

Secondary

MeasureTime frame
adverse event other than AESI, technical success rate of stent insertion, migration rates of stent, technical success rates of removal of stent, passage rate of colonoscopy after stent removal imprpvement of subjective symptoms using visual analog scale duration of hospital stay (from stent insertion to discharge) procedure time of stent insertion The rate of re-stenosis, re-intervention and surgery

Contacts

Public ContactRintaro Moroi

Tohoku University Hospital

rintaro.moroi.e8@tohoku.ac.jp+81-22-717-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026